Log In
BCIQ
Print this Print this
 

Histone deacetylase (HDAC)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Histone deacetylase (HDAC)

BCIQ
Print ChartPrint this
Marketed, 2 Marketed, 4 Approved, 1 Phase III, 3 Phase II, 1 Phase II, 1 Phase II, 12 Phase II, 1 Phase I/II, 1 Phase I/II, 1 Phase I/II, 1 Phase I/II, 5 Phase I, 2 Phase I, 1 Phase I, 11 Phase I, 1 Preclinical, 1 Preclinical, 1 Preclinical, 8
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIApprovedMarketed
Autoimmune

-

1

-

1

-

-

-

Cancer

8

11

5

12

3

1

4

Diagnostic

1

-

-

-

-

-

-

Endocrine / Metabolic

1

-

1

-

-

-

-

Hematology

-

1

-

1

-

-

-

Infectious

-

-

1

-

-

-

-

Neurology

-

2

-

1

-

-

2

Transplant

-

-

1

-

-

-

-




 Products Targeting Histone deacetylase (HDAC)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

26

$23,141.2M

$472.1M

$2,360.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today